Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1037 studies found for:    Open Studies | "Connective Tissue Diseases"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
2 Recruiting Undifferentiated Connective Tissue Disease Registry
Condition: Undifferentiated Connective Tissue Disease
Intervention: Other: Observation
3 Recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
4 Recruiting Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
Conditions: Connective Tissue Disease;   Pulmonary Hypertension
Intervention:
5 Unknown † A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
Conditions: Hypertension, Pulmonary;   Connective Tissue Disease
Intervention: Drug: bosentan
6 Recruiting Evaluation and Treatment of Patients With Connective Tissue Disease
Condition: Connective Tissue Disorders
Intervention:
7 Recruiting Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
Conditions: Mixed Connective Tissue Disease (MCTD);   Systemic Lupus Erythematosus (SLE)
Intervention:
8 Recruiting Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients
Conditions: Connective Tissue Diseases;   Pulmonary Hypertension
Intervention:
9 Not yet recruiting Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon Secondary to Connective Tissue Disease
Interventions: Drug: Vascana (0.9% nitroglycerin cream);   Drug: Vehicle (placebo)
10 Unknown † The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Connective Tissue Disease
Intervention:
11 Not yet recruiting Role of Mesenchymal Stem Cells in Fat Grafting
Conditions: Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
12 Unknown † Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Connective Tissue Disease
Intervention: Behavioral: exercise training
13 Not yet recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
14 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
15 Recruiting Determination of Kidney Function
Conditions: Kidney Disease;   Proteinuria;   Autoimmune / Connective Tissue Diseases
Intervention:
16 Recruiting A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)
Conditions: Rheumatoid Arthritis;   Musculoskeletal and Connective Tissue Diseases
Interventions: Drug: Adalimumab;   Other: Placebo
17 Unknown † Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
Conditions: Pneumonia, Pneumocystis;   Prevention & Control
Intervention: Drug: Trimethoprim/Sulfamethoxazole
18 Recruiting Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
Conditions: Systemic Lupus Erythematosus;   Rheumatoid Arthritis;   Sharp's Syndrome
Interventions: Other: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs;   Other: Lipoaspiration
19 Unknown † Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Conditions: Systemic Sclerosis;   Shortness of Breath;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
20 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years